2011. Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals . Brazilian Journal of Pharmaceutical Sciences. 47, 1 (Mar. 2011), 31–38. DOI:https://doi.org/10.1590/S1984-82502011000100005.